Home » Topics » Regulatory » Patents

Patents
RSS

Novartis patents novel HBV HBsAg secretion inhibitors

May 10, 2018

New EAAT3 inhibitors divulged by Roche

May 10, 2018

Bristol-Myers Squibb presents novel nuclear receptor ROR-gamma inverse agonists

May 9, 2018

Merck & Co. patents lysine-specific demethylase 5B inhibitors

May 9, 2018

New RIP-1 inhibitors discovered at Roche, Genentech

May 9, 2018

Cellcentric divulges new KAT3 and/or CREB-binding protein inhibitors

May 9, 2018

Novartis describes novel IKACh channel blockers

May 9, 2018

Novel serine palmitoyltransferase inhibitors identified at Takeda

May 9, 2018

Secarna Pharmaceuticals patents novel anti-CD39 immunosuppression-reverting oligonucleotides

May 8, 2018

Sage Therapeutics identifies GluN2A and/or GluN2B NAMs

May 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...